Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Across is a South Korean biotechnology company specializing in the research, development, and manufacture of hyaluronic acid-based medical devices. The company is most recognized for its Revolax brand of dermal fillers, which are utilized globally for aesthetic procedures including wrinkle reduction and facial contouring. Across utilizes a proprietary cross-linking technology to produce high-viscoelasticity fillers that provide natural-looking and long-lasting results. Since becoming a subsidiary of Hugel, a leader in the Korean medical aesthetics industry, Across has expanded its manufacturing capabilities and international distribution. The company maintains a strong focus on quality control and innovation within the dermatology and plastic surgery sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Across Korea.